Overview
The primary objective of the study is to determine the benefits of the food product EPAX Omega 3-9-11 on skin function.
Benefits (if any) will be determined by evaluating biophysical measurements of the face and inner forearm. Moreover, the study will determine the dosage effect of Omega-3-9-11 on these measurements.
Description
The long chain mono-unsaturated fatty acids, cetoleic acid (C22:1 n-11) and gondoic acid (C20:1 n-9) found in some North Atlantic fish have been shown to lower inflammatory markers. This has been shown in preclinical studies with particular effect in adipose tissue, and in a human clinical study measuring redness of the face. Omega-3 is also known for reducing skin erythema evoked as a response to UVB exposure, and to decreasing systemic inflammatory biomarkers.
This provides a hypothesis that a combination oil with known bioaccumulation in both subcutaneous fat and in dermal/epidermal layers will contribute to healthy skin function, as shown by a reduction in inflammatory markers and skin erythema and improved barrier function.
The study will recruit subjects to one of 3 arms, a placebo, a low dose and a high dose of omega 3-9-11. Subjects will receive capsules for 3 months and undergo a series of measurements at baseline, 6 weeks and 12 weeks.
Eligibility
Inclusion Criteria:
- Volunteers who are able to provide signed informed consent
- Healthy male or female volunteers between the ages of 35 and 65 years
- Volunteers with a self-perceived history of atopic skin, prone to redness and/or dryness
Exclusion Criteria:
- Females who are pregnant, breast feeding, or have given birth within the previous 6 weeks or are planning to be pregnant during the study
- Volunteers with previous experience of intolerance or allergic reactions to fish or fish products
- Volunteers with an active skin disorder or a significant history of skin disorders (e.g. psoriasis, eczema, vitiligo, pityriasis versicolor, acne) which in the opinion of a trained assessor or dermatologist may affect the test results
- Volunteers currently taking or who have recently taken antihistamines, antibiotics, systemic anti-inflammatory drugs during the previous week
- Volunteers currently taking or who have recently taken retinoids, immunosuppressive drugs, anti-cancer drugs during the six previous months
- Volunteers who have started, stopped or changed hormonal treatment (including contraceptive pills) in the five previous weeks
- Volunteers whose skin has been exposed to excessive levels of sun or UV rays during the previous month
- Volunteers who are suffering from chronic asthma, a malfunction of the lymphatic system, or an auto immune deficiency disease (e.g. lupus, thyroiditis)
- Volunteers with a history of skin tumours or malignant disease
- Volunteers who have participated in any clinical study involving the test sites within the previous month
- Volunteers taking fish oil supplements or other lipid-based supplements regularly during the last 4 weeks